NCT04257955View on ClinicalTrials.gov

COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

April 19, 2022

Study Completion Date

April 19, 2022

Conditions
Pancreatic CancerInteractionDiagnosis
Interventions
BEHAVIORAL

Interview and evaluation of Engagement

(i) the completion of the scheduled outpatients visit (ii) filling of the PHE-Scale® questionnaire by the patient to investigate the level of engagement and (iii) the completion of a semi-structured interview to assess the rate of understanding of the information received from the doctor.

Trial Locations (1)

Unknown

Gabriele Capurso, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT04257955 - COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer | Biotech Hunter | Biotech Hunter